228 related articles for article (PubMed ID: 26735576)
1. Double-strand break repair and colorectal cancer: gene variants within 3' UTRs and microRNAs binding as modulators of cancer risk and clinical outcome.
Naccarati A; Rosa F; Vymetalkova V; Barone E; Jiraskova K; Di Gaetano C; Novotny J; Levy M; Vodickova L; Gemignani F; Buchler T; Landi S; Vodicka P; Pardini B
Oncotarget; 2016 Apr; 7(17):23156-69. PubMed ID: 26735576
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in microRNA binding sites of mucin genes as predictors of clinical outcome in colorectal cancer patients.
Vymetalkova V; Pardini B; Rosa F; Jiraskova K; Di Gaetano C; Bendova P; Levy M; Veskrnova V; Buchler T; Vodickova L; Naccarati A; Vodicka P
Carcinogenesis; 2017 Jan; 38(1):28-39. PubMed ID: 27803053
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis.
Schneiderova M; Naccarati A; Pardini B; Rosa F; Gaetano CD; Jiraskova K; Opattova A; Levy M; Veskrna K; Veskrnova V; Buchler T; Landi S; Vodicka P; Vymetalkova V
Mutagenesis; 2017 Oct; 32(5):533-542. PubMed ID: 29048575
[TBL] [Abstract][Full Text] [Related]
4. Variation within 3'-UTRs of base excision repair genes and response to therapy in colorectal cancer patients: A potential modulation of microRNAs binding.
Pardini B; Rosa F; Barone E; Di Gaetano C; Slyskova J; Novotny J; Levy M; Garritano S; Vodickova L; Buchler T; Gemignani F; Landi S; Vodicka P; Naccarati A
Clin Cancer Res; 2013 Nov; 19(21):6044-56. PubMed ID: 24036853
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1, RAD51 and RAD52 involved in HRR pathway genes and risk of breast cancer in China.
Wu Z; Wang P; Song C; Wang K; Yan R; Li J; Dai L
Mol Genet Genomics; 2015 Jun; 290(3):1141-53. PubMed ID: 25566853
[TBL] [Abstract][Full Text] [Related]
6. Single nucleotide polymorphisms within MicroRNAs, MicroRNA targets, and MicroRNA biogenesis genes and their impact on colorectal cancer survival.
Mullany LE; Herrick JS; Wolff RK; Slattery ML
Genes Chromosomes Cancer; 2017 Apr; 56(4):285-295. PubMed ID: 27859935
[TBL] [Abstract][Full Text] [Related]
7. Genetic variations in microRNA-binding sites of solute carrier transporter genes as predictors of clinical outcome in colorectal cancer.
Bendova P; Pardini B; Susova S; Rosendorf J; Levy M; Skrobanek P; Buchler T; Kral J; Liska V; Vodickova L; Landi S; Soucek P; Naccarati A; Vodicka P; Vymetalkova V
Carcinogenesis; 2021 Apr; 42(3):378-394. PubMed ID: 33319241
[TBL] [Abstract][Full Text] [Related]
8. A variant at a potentially functional microRNA-binding site in BRIP1 was associated with risk of squamous cell carcinoma of the head and neck.
Liu H; Gao F; Dahlstrom KR; Li G; Sturgis EM; Zevallos JP; Wei Q; Liu Z
Tumour Biol; 2016 Jun; 37(6):8057-66. PubMed ID: 26711789
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation in microRNA-binding site and prognosis of patients with colorectal cancer.
Kim JG; Chae YS; Lee SJ; Kang BW; Park JY; Lee EJ; Jeon HS; Park JS; Choi GS
J Cancer Res Clin Oncol; 2015 Jan; 141(1):35-41. PubMed ID: 25079514
[TBL] [Abstract][Full Text] [Related]
10. Association analysis of miRNA-related genetic polymorphisms in miR-143/145 and KRAS with colorectal cancer susceptibility and survival.
Wang D; Liu Q; Ren Y; Zhang Y; Wang X; Liu B
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33825830
[TBL] [Abstract][Full Text] [Related]
11. The association of a single-nucleotide variant in the microRNA-146a with advanced colorectal cancer prognosis.
Santos JSD; Zunta GL; Negrini AB; Ribeiro MSG; Martinez CAR; Ribeiro ML; Lourenço GJ; Ortega MM
Tumour Biol; 2020 May; 42(5):1010428320923856. PubMed ID: 32438863
[TBL] [Abstract][Full Text] [Related]
12. The polymorphisms of miRNA-binding site in MLH3 and ERCC1 were linked to the risk of colorectal cancer in a case-control study.
Zhang Q; Zheng X; Li X; Sun D; Xue P; Zhang G; Xiao M; Cai Y; Jin C; Yang J; Wu S; Lu X
Cancer Med; 2018 Apr; 7(4):1264-1274. PubMed ID: 29516665
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in microRNA target sites modulate risk of lymphoblastic and myeloid leukemias and affect microRNA binding.
Dzikiewicz-Krawczyk A; Macieja A; Mały E; Januszkiewicz-Lewandowska D; Mosor M; Fichna M; Strauss E; Nowak J
J Hematol Oncol; 2014 Jun; 7():43. PubMed ID: 24886876
[TBL] [Abstract][Full Text] [Related]
14. Association between miRNA-binding site polymorphisms in double-strand break repair genes and risk of recurrence in patients with squamous cell carcinomas of the non-oropharynx.
Zhu L; Sturgis EM; Lu Z; Zhang H; Wei P; Wei Q; Li G
Carcinogenesis; 2017 Apr; 38(4):432-438. PubMed ID: 28334093
[TBL] [Abstract][Full Text] [Related]
15. The Effect of
Alhadheq AM; Purusottapatnam Shaik J; Alamri A; Aljebreen AM; Alharbi O; Almadi MA; Alhadeq F; Azzam NA; Semlali A; Alanazi M; Bazzi MD; Reddy Parine N
Dis Markers; 2016; 2016():8289293. PubMed ID: 27746584
[No Abstract] [Full Text] [Related]
16. Predictive impact of genetic polymorphisms in DNA repair genes on susceptibility and therapeutic outcomes to colorectal cancer patients.
Sun K; Gong A; Liang P
Tumour Biol; 2015 Mar; 36(3):1549-59. PubMed ID: 25355595
[TBL] [Abstract][Full Text] [Related]
17. SNPs in microRNA-binding sites in the ITGB1 and ITGB3 3'-UTR increase colorectal cancer risk.
Ye P; Li Z; Jiang H; Liu T
Cell Biochem Biophys; 2014 Sep; 70(1):601-7. PubMed ID: 24777809
[TBL] [Abstract][Full Text] [Related]
18. A RAD52 genetic variant located in a miRNA binding site is associated with glioma risk in Han Chinese.
Lu C; Chen YD; Han S; Wei J; Ge Y; Pan W; Jiang T; Qiu XG; Yang M
J Neurooncol; 2014 Oct; 120(1):11-7. PubMed ID: 25012956
[TBL] [Abstract][Full Text] [Related]
19. The rs17084733 variant in the
Ravegnini G; Serrano C; Simeon V; Sammarini G; Nannini M; Roversi E; Urbini M; Ferrè F; Ricci R; Tarantino G; Pantaleo MA; Hrelia P; Angelini S
Epigenetics; 2019 Jun; 14(6):545-557. PubMed ID: 30983504
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx.
Zhu L; Sturgis EM; Zhang H; Lu Z; Tao Y; Wei Q; Li G
Int J Cancer; 2017 Oct; 141(7):1355-1364. PubMed ID: 28646528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]